Dr. Mark E. Schneiderhan is a Board Certified Psychiatric Pharmacist who has been providing psychopharmacy consultation and teaching since 1995. He has a B.S. Pharmacy degree from Ferris State University in Michigan and a post-B.S. Pharm.D. degree from the University of Kentucky. In 1994, he completed a 2 year post-doctoral residency and fellowship at Western Missouri Mental Health center in Kansas City, Missouri. He is currently a Clinical Assistant Professor at the University of Illinois at Chicago, College of Pharmacy. He is a current member of ASHP, ICHP, ACCP, APHA and CPNP
Dr. Schneiderhan has extensive experience in problem-based learning paradigms and his teaching responsibilities includes: coordinating and teaching psychopharmacology and therapeutics for 2 nd year pharmacy students; PGY-1 psychopharmacology lectures; basic psychopharmcology for graduate-level nurses at the College of Nursing; basic psychopharmacy principles to psychology interns and problem-based assessment and mental status testing in the College of Medicine.
Dr. Schneiderhan's clinical services includes: metabolic consultation service (BMI, hip/waist measurements, blood-pressure/pulse, capillary glucose), therapeutic drug monitoring/pharmacokinetics, medication histories, treatment planning, extra-pyramidal side effects (EPS) assessments using the AIMS or DISCUS rating scales, clozapine dosing and monitoring, Haldol/Prolixin Decanoate dosing and monitoring and general psychopharmacology consultation for medication refractory cases. In addition, he is currently facilitating patient group medication education to address medications and side-effects such as medication-related weight gain.
is research interests are mainly in the area of endocrinology including diabetes and medication-related weight gain side effects, especially with second generation antipychotics agents.
Department of Psychiatry- Personal Page |